Search

Your search keyword '"Ham, S"' showing total 1,549 results

Search Constraints

Start Over You searched for: Author "Ham, S" Remove constraint Author: "Ham, S"
1,549 results on '"Ham, S"'

Search Results

1. Correction: the heterogeneous effects of COVID-19 lockdowns on crime across the world

2. The heterogeneous effects of COVID-19 lockdowns on crime across the world

4. Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy

5. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

7. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses

8. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

9. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

11. Differences in IgG autoantibody Fab glycosylation across autoimmune diseases

12. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies

13. Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases

14. Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study

15. TCR-CD3 signal strength regulates plastic coexpression of IL-4 and IFN-γ in Tfh-like cells.

16. Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization

17. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination

18. Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

19. Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization.

20. Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases.

21. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination

22. T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination

23. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses

24. Pain and fatigue in adult patients with multiple osteochondromas: The Netherlands.

25. Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod

26. Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection

30. FMOS near-IR spectroscopy of Herschel selected galaxies: star formation rates, metallicity and dust attenuation at z~1

31. Higgs boson masses in an extension of the MSSM with vector-like quarks

32. Electroweak phase transition in an extension of the Standard Model with scalar color octet

33. Electroweak baryogenesis in the MSSM with vector-like quarks

34. Study of Higgs self couplings of a supersymmetric $E_6$ model at the International Linear Collider

35. Explicit CP violation in the Dine-Seiberg-Thomas model

36. Possibility of spontaneous CP violation in Higgs physics beyond the minimal supersymmetric standard model

37. Exotic quark effects on the Higgs sector of the USSM at the LHC

38. Dispersion and Phase Exchange Process of Chemically Reactive Solute Through Circular Tube.

39. Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod.

40. Longitudinal increase of humoral responses after four SARS-CoV-2 vaccinations and infection in MS patients on fingolimod

47. Spontaneous CP violation in the triplet extended supersymmetric standard model

48. Higgs bosons of a supersymmetric $E_6$ model at the Large Hadron Collider

49. Neutral Higgs bosons in the MNMSSM with explicit CP violation

50. Higgs bosons of a supersymmetric $U(1)'$ model at the ILC

Catalog

Books, media, physical & digital resources